Federal Reserve

  • Most Popular
  • Most Shared

REUTERS SHOWCASE

Monsoon Floods

Monsoon Floods

Death toll in Uttarakhand monsoon floods crosses 150  Full Article 

Auto Market

Auto Market

Tata Motors upgrades cars as rivals launch new ones.  Full Article 

EU Fines Ranbaxy

EU Fines Ranbaxy

EU fines Ranbaxy, others for blocking cheaper drugs.  Full Article 

Business Optimism

Business Optimism

Asian businesses optimistic; sentiment in India falls.  Full Article 

Financing Trouble

Financing Trouble

U.S. court lets stand Ex-Im Bank loan for Air India.  Full Article 

Euro Economy

Euro Economy

Half-way to lost decade, Europe's growth task as tough as ever.  Full Article 

Buy, Sell or Hold?

Buy, Sell or Hold?

Confused while buying stocks? Get buy, sell or hold recommendations from VantageTrade.  Full Coverage 

Reuters India Mobile

Reuters India Mobile

Get the latest news on the go. Visit Reuters India on your mobile device.  Full Coverage 

MARKET EYE-Shasun Pharmaceuticals falls on Vertex drug warning

Related Topics

Stocks

   
The new Xbox One controller (R), next to the previous controller during a press event unveiling Microsoft's new Xbox One in Redmond, Washington May 21, 2013. REUTERS/Nick Adams/Files
Technology

Microsoft reverses position on Xbox One

Microsoft says that users of its forthcoming Xbox One game console will be able to play games offline without an Internet connection, and will be able to lend or sell used disc-based games.  Full Article 

Thu Dec 20, 2012 2:03pm IST

* Shasun Pharmaceuticals falls 6 percent after its
Vertex Pharmaceuticals warned on Wednesday its
hepatitis C drug Incivek, which is used in conjunction with two
other products, can cause serious, potentially fatal skin
reactions. 
* Shasun has a long-term agreement with Vertex for supply of
active pharmaceutical ingredient for the Hepatitis C drug.
* "There would be incremental impact on Shasun as about 25
percent of FY13 profits were expected to come in from Incivek
supply," said Surya Patra, an analyst tracking the sector at
Systematix Shares & Stocks.

 (abhishek.vishnoi@thomsonreuters.com /;
abhishek.vishnoi.reuters.com@reuters.net)
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.